Request Deal Involvement

CPE and Mirae Asset led a $100m Series B round in JW Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

JW THERAPEUTICS

target

JW THERAPEUTICS

CPE CAPITAL

bidder

CPE CAPITAL

MIRAE ASSET FINANCIAL GROUP

bidder

MIRAE ASSET FINANCIAL GROUP

CR-CP LIFE SCIENCE FUND

bidder

CR-CP LIFE SCIENCE FUND

ORIZA HOLDINGS

bidder

ORIZA HOLDINGS

LOYAL VALLEY CAPITAL

bidder

LOYAL VALLEY CAPITAL

TEMASEK HOLDINGS LIMITED

bidder

TEMASEK HOLDINGS LIMITED

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

JUNO THERAPEUTICS INC

bidder

JUNO THERAPEUTICS INC

WUXI APPTEC

bidder

WUXI APPTEC

HONGSHAN (EX-SEQUOIA CAPITAL CHINA)

bidder

HONGSHAN (EX-SEQUOIA CAPITAL CHINA)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite